Another investigation revealed that CDKN1B/p27 and CDKN1C/p57 weredownregulated in HCC cells as direct targets of miR-221; the upregulation of miR-221can promote cell proliferation and increase the progression to S phase [[57]]. Here, CDKN1B is linked to hepatocellular carcinoma.